Anglikang (002940.SZ): Three products are expected to be selected for the twelfth batch of centralized bulk procurement.

Zhito Finance APP News, Anglikang (002940.SZ) announced that recently, the company and its subsidiary Fujian Haixi United Pharmaceutical Co., Ltd. (hereinafter referred to as "Haixi Pharmaceutical") participated in the bidding work organized by the National Organization for Drug Centralized Procurement Office for the 12th batch of national centralized volume-based procurement of pharmaceuticals. According to the "Proposed Selection Results for the 12th Batch of National Organization for Drug Centralized Volume-based Procurement (GY-YD2026-1)" released by the National Organization for Drug Centralized Procurement Office on July 31, 2026, the company's metformin sustained-release tablets, sacubitril valsartan tablets, and Haixi Pharmaceutical's inhaled sevoflurane are proposed to be selected in the 12th batch of centralized volume-based procurement.